TIGECYCLINE

TIGECYCLINE was reported 6221 times

TIGECYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG CLEARANCE 4 0.4444
1 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 4 0.3636
2 EOSINOPHIL COUNT NORMAL 3 0.2143
3 FLAVOBACTERIUM INFECTION 9 0.2045
4 KOCURIA INFECTION 3 0.1875
5 GALLSTONE ILEUS 6 0.1364
6 HYPOFIBRINOGENAEMIA 98 0.0988
7 ACUTE GRAFT VERSUS HOST DISEASE ORAL 3 0.0968
8 BLOOD FIBRINOGEN DECREASED 99 0.0867
9 ADJUSTED CALCIUM DECREASED 9 0.0849
10 HAEMORRHAGIC PNEUMONIA 5 0.0806
11 PARASPINAL ABSCESS 12 0.0774
12 PURPURA NON-THROMBOCYTOPENIC 6 0.0723
13 MYCOBACTERIUM ABSCESSUS INFECTION 50 0.0699
14 ACINETOBACTER BACTERAEMIA 13 0.0691
15 HAEMORRHAGIC NECROTIC PANCREATITIS 5 0.0667
16 ACINETOBACTER INFECTION 71 0.0648
17 PROCALCITONIN DECREASED 4 0.0571
18 ANTIBIOTIC ASSOCIATED COLITIS 2 0.0541
19 DYSBIOSIS 44 0.0536
20 GEOTRICHUM INFECTION 11 0.0521
21 BILOMA 7 0.0496
22 HAEMOSTASIS 8 0.0491
23 SUPERINFECTION FUNGAL 4 0.0471
24 THROMBIN TIME PROLONGED 11 0.0445
25 BLOOD UREA 2 0.0435
26 MYCOBACTERIAL PERITONITIS 4 0.0421
27 TONSILLITIS BACTERIAL 8 0.0412
28 ACINETOBACTER TEST POSITIVE 8 0.0412
29 ATYPICAL MYCOBACTERIUM TEST POSITIVE 4 0.0412
30 MORGANELLA INFECTION 12 0.0410
31 MYCOBACTERIUM CHELONAE INFECTION 29 0.0392
32 BACTERIAL PERICARDITIS 2 0.0339
33 BILE DUCT NECROSIS 2 0.0328
34 TRICHOSPORON INFECTION 13 0.0321
35 COAGULATION TIME PROLONGED 45 0.0291
36 BILE ACIDS INCREASED 5 0.0282
37 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 6 0.0267
38 KLEBSIELLA BACTERAEMIA 23 0.0242
39 NEUROMUSCULAR BLOCKADE 5 0.0223
40 PATHOGEN RESISTANCE 203 0.0222
41 OTOTOXICITY 40 0.0216
42 HEPATIC INFARCTION 8 0.0212
43 KLEBSIELLA INFECTION 103 0.0203
44 SERRATIA BACTERAEMIA 3 0.0203
45 MEDIASTINITIS 11 0.0190
46 RESPIRATORY PARALYSIS 3 0.0187
47 VANCOMYCIN INFUSION REACTION 7 0.0186
48 PENILE OEDEMA 6 0.0184
49 COAGULATION FACTOR DECREASED 5 0.0183
50 OSTEOMYELITIS BACTERIAL 5 0.0182
51 ACID BASE BALANCE ABNORMAL 4 0.0179
52 DISSEMINATED MUCORMYCOSIS 7 0.0178
53 EOSINOPHILIC PNEUMONIA ACUTE 15 0.0173
54 ACOUSTIC NEUROMA 7 0.0171
55 CITROBACTER INFECTION 7 0.0163
56 PROCALCITONIN INCREASED 19 0.0162
57 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 5 0.0162
58 COMA HEPATIC 12 0.0162
59 AMYLASE ABNORMAL 2 0.0160
60 DEHISCENCE 3 0.0159
61 MITOCHONDRIAL TOXICITY 13 0.0158
62 DYSSOMNIA 3 0.0156
63 COOMBS NEGATIVE HAEMOLYTIC ANAEMIA 3 0.0154
64 KLEBSIELLA TEST POSITIVE 10 0.0154
65 ENTEROCOCCAL INFECTION 73 0.0151
66 ABDOMINAL WALL INFECTION 2 0.0149
67 MULTIPLE-DRUG RESISTANCE 46 0.0148
68 SPLENIC ABSCESS 6 0.0147
69 STENOTROPHOMONAS INFECTION 20 0.0147
70 SUPERINFECTION 22 0.0147
71 MYCOBACTERIUM HAEMOPHILUM INFECTION 4 0.0140
72 BURKHOLDERIA CEPACIA COMPLEX INFECTION 4 0.0140
73 PANCREATIC INJURY 4 0.0131
74 COAGULOPATHY 216 0.0130
75 FUNGAEMIA 20 0.0127
76 ALLOGENIC STEM CELL TRANSPLANTATION 2 0.0127
77 EXTRAVASATION BLOOD 3 0.0126
78 HERPES SIMPLEX HEPATITIS 3 0.0125
79 VITAMIN K DEFICIENCY 5 0.0124
80 RESPIRATORY MUSCLE WEAKNESS 4 0.0123
81 HYPOCAPNIA 5 0.0120
82 ICHTHYOSIS 3 0.0119
83 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
84 RESPIRATORY TRACT HAEMORRHAGE 7 0.0117
85 LEUKAEMOID REACTION 3 0.0115
86 XERODERMA 3 0.0112
87 ABSCESS BACTERIAL 4 0.0110
88 LUNG INFECTION PSEUDOMONAL 6 0.0108
89 URINARY TRACT INFECTION FUNGAL 6 0.0105
90 HEPATIC ARTERY THROMBOSIS 3 0.0102
91 HYPOPROTHROMBINAEMIA 3 0.0100
92 HYPOGONADISM 10 0.0099
93 SCROTAL OEDEMA 7 0.0098
94 BONE ABSCESS 4 0.0098
95 PNEUMONIA PSEUDOMONAL 15 0.0098
96 EPIDERMOLYSIS BULLOSA 3 0.0097
97 POST PROCEDURAL BILE LEAK 3 0.0096
98 PROTHROMBIN LEVEL DECREASED 9 0.0096
99 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48 0.0095
100 PULMONARY MUCORMYCOSIS 5 0.0095
101 BILIRUBIN CONJUGATED INCREASED 22 0.0094
102 PSEUDOMONAL BACTERAEMIA 8 0.0094
103 MYCOBACTERIAL INFECTION 16 0.0093
104 COAGULATION FACTOR V LEVEL DECREASED 3 0.0092
105 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 19 0.0089
106 OEDEMATOUS PANCREATITIS 5 0.0089
107 DRUG RESISTANCE 225 0.0088
108 AMYLASE INCREASED 32 0.0087
109 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 33 0.0086
110 PANCREATITIS HAEMORRHAGIC 4 0.0086
111 RENAL ABSCESS 7 0.0085
112 CYTOMEGALOVIRUS HEPATITIS 3 0.0085
113 DELAYED GRAFT FUNCTION 6 0.0084
114 FUNGAL SEPSIS 7 0.0084
115 PROTEUS INFECTION 6 0.0084
116 TINEA VERSICOLOUR 3 0.0083
117 BACTERIAL SEPSIS 27 0.0083
118 MEGACOLON 13 0.0083
119 PANCREATITIS NECROTISING 19 0.0083
120 DEAFNESS NEUROSENSORY 27 0.0082
121 PSEUDOMONAS INFECTION 70 0.0082
122 PNEUMONIA KLEBSIELLA 15 0.0082
123 CEREBRAL ASPERGILLOSIS 5 0.0081
124 ABDOMINAL INFECTION 20 0.0078
125 ABDOMINAL WALL HAEMORRHAGE 2 0.0077
126 C-REACTIVE PROTEIN DECREASED 5 0.0077
127 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 25 0.0076
128 ENTEROCOCCAL BACTERAEMIA 8 0.0075
129 MYASTHENIA GRAVIS CRISIS 11 0.0074
130 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 3 0.0074
131 TRICHOGLOSSIA 3 0.0073
132 KLEBSIELLA SEPSIS 8 0.0071
133 GLUCOCORTICOID DEFICIENCY 3 0.0071
134 GRAFT VERSUS HOST DISEASE IN LIVER 5 0.0070
135 LIPASE INCREASED 53 0.0069
136 GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0068
137 ALVEOLAR PROTEINOSIS 4 0.0068
138 PANCREATITIS ACUTE 152 0.0068
139 SUSPECTED OFF LABEL USE 30 0.0066
140 ASPERGILLUS TEST POSITIVE 2 0.0065
141 PROTHROMBIN TIME RATIO DECREASED 4 0.0064
142 BRONCHIAL HAEMORRHAGE 2 0.0064
143 ATYPICAL MYCOBACTERIAL INFECTION 9 0.0064
144 PROTHROMBIN TIME PROLONGED 38 0.0063
145 SUPERINFECTION BACTERIAL 5 0.0063
146 PSEUDOMONAL SEPSIS 11 0.0063
147 RED BLOOD CELLS URINE POSITIVE 6 0.0062
148 ENTEROCOCCAL SEPSIS 5 0.0062
149 ABDOMINAL WALL ABSCESS 4 0.0062
150 CARDIAC VALVE VEGETATION 3 0.0062
151 ENTEROCOCCUS TEST POSITIVE 4 0.0062
152 SYSTEMIC CANDIDA 15 0.0060
153 LIVER ABSCESS 19 0.0059
154 PSEUDOMEMBRANOUS COLITIS 13 0.0058
155 PERITONEAL HAEMORRHAGE 8 0.0058
156 SEPTIC SHOCK 243 0.0056
157 BACTERAEMIA 66 0.0056
158 BRONCHOSTENOSIS 3 0.0055
159 PANCREATIC ENZYMES INCREASED 8 0.0055
160 SERRATIA INFECTION 4 0.0054
161 DRUG CLEARANCE DECREASED 7 0.0054
162 CLOSTRIDIUM DIFFICILE COLITIS 56 0.0053
163 LYMPHOCYTE MORPHOLOGY ABNORMAL 3 0.0052
164 COAGULATION TEST ABNORMAL 4 0.0052
165 METHAEMOGLOBINAEMIA 12 0.0052
166 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 4 0.0051
167 ENDOCARDITIS 26 0.0051
168 ACUTE LUNG INJURY 6 0.0051
169 ASPERGILLUS INFECTION 33 0.0050
170 DIAPHRAGMATIC PARALYSIS 3 0.0050
171 URINARY TRACT INFECTION PSEUDOMONAL 3 0.0050
172 SPUTUM CULTURE POSITIVE 4 0.0049
173 VESTIBULAR DISORDER 6 0.0049
174 RENAL INFARCT 7 0.0048
175 TOXIC SHOCK SYNDROME 3 0.0048
176 ENTEROBACTER INFECTION 8 0.0048
177 ESCHERICHIA INFECTION 39 0.0047
178 MULTI-ORGAN FAILURE 80 0.0046
179 MULTI-ORGAN DISORDER 9 0.0046
180 CHOLESTATIC LIVER INJURY 10 0.0045
181 HYPERLACTACIDAEMIA 12 0.0045
182 SYSTEMIC MYCOSIS 5 0.0043
183 MUCORMYCOSIS 11 0.0042
184 HYPOPROTEINAEMIA 8 0.0042
185 BLOOD BILIRUBIN INCREASED 113 0.0042
186 ESCHERICHIA TEST POSITIVE 5 0.0042
187 HEPATITIS CHOLESTATIC 25 0.0041
188 CHRONIC RESPIRATORY FAILURE 5 0.0041
189 HYPOCOAGULABLE STATE 4 0.0041
190 CYCLIC VOMITING SYNDROME 3 0.0041
191 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
192 NOSOCOMIAL INFECTION 9 0.0041
193 MULTIPLE ORGAN DYSFUNCTION SYNDROME 112 0.0039
194 BACTERIAL INFECTION 73 0.0039
195 DEBRIDEMENT 3 0.0039
196 HAEMATOLOGICAL MALIGNANCY 11 0.0039
197 NEPHROPATHY TOXIC 43 0.0038
198 METAPNEUMOVIRUS INFECTION 3 0.0038
199 SOFT TISSUE INFECTION 7 0.0038
200 LUNG ABSCESS 8 0.0038
201 HAEMODYNAMIC INSTABILITY 29 0.0038
202 CANDIDA INFECTION 64 0.0038
203 ANTIPSYCHOTIC DRUG LEVEL DECREASED 2 0.0038
204 SKIN BACTERIAL INFECTION 3 0.0037
205 STRONGYLOIDIASIS 6 0.0037
206 JAUNDICE CHOLESTATIC 13 0.0037
207 PANCREATITIS RELAPSING 3 0.0037
208 PSEUDOMONAS TEST POSITIVE 3 0.0037
209 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 93 0.0036
210 MYOCARDIAL INJURY 4 0.0036
211 BLOOD UREA INCREASED 59 0.0035
212 BRONCHOPULMONARY ASPERGILLOSIS 27 0.0035
213 PROTEIN TOTAL DECREASED 13 0.0034
214 SPLENIC INFARCTION 6 0.0034
215 HYPERTRIGLYCERIDAEMIA 20 0.0034
216 INCISION SITE PAIN 4 0.0034
217 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 9 0.0034
218 THERAPEUTIC PRODUCT CROSS-REACTIVITY 3 0.0034
219 INTRA-ABDOMINAL HAEMORRHAGE 8 0.0034
220 PARVOVIRUS B19 INFECTION 3 0.0034
221 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
222 CANDIDA SEPSIS 3 0.0033
223 DIABETES INSIPIDUS 8 0.0033
224 OROPHARYNGEAL CANDIDIASIS 3 0.0033
225 WOUND HAEMORRHAGE 12 0.0032
226 RENAL TUBULAR DISORDER 9 0.0032
227 PERIPHERAL SENSORIMOTOR NEUROPATHY 4 0.0032
228 NEUTROPHIL PERCENTAGE INCREASED 4 0.0032
229 COR PULMONALE 3 0.0031
230 ANURIA 27 0.0031
231 LIVER INJURY 77 0.0031
232 CHOLESTASIS 60 0.0031
233 BRONCHIECTASIS 21 0.0031
234 HEPATOTOXICITY 68 0.0031
235 PNEUMONIA FUNGAL 12 0.0030
236 PYURIA 3 0.0030
237 INFLAMMATORY MARKER INCREASED 15 0.0030
238 TRANSAMINASES INCREASED 67 0.0030
239 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
240 HYPERCAPNIA 9 0.0030
241 BONE DEFORMITY 2 0.0030
242 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
243 POSTOPERATIVE WOUND INFECTION 20 0.0030
244 EFFUSION 4 0.0029
245 PANCREATITIS 151 0.0029
246 RESPIRATORY ACIDOSIS 11 0.0028
247 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
248 GRAFT VERSUS HOST DISEASE 20 0.0028
249 PNEUMOMEDIASTINUM 5 0.0028
250 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
251 B-CELL TYPE ACUTE LEUKAEMIA 2 0.0027
252 LISTERIOSIS 3 0.0027
253 DISORGANISED SPEECH 5 0.0027
254 CLOSTRIDIAL INFECTION 9 0.0027
255 HEPATIC FAILURE 80 0.0027
256 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
257 MECHANICAL VENTILATION 5 0.0026
258 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 13 0.0026
259 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
260 HYPERBILIRUBINAEMIA 27 0.0026
261 SHOCK HAEMORRHAGIC 21 0.0026
262 ESCHERICHIA BACTERAEMIA 6 0.0025
263 EOSINOPHILIC PNEUMONIA 8 0.0025
264 BLOOD ALKALINE PHOSPHATASE INCREASED 63 0.0025
265 ABDOMINAL ADHESIONS 8 0.0025
266 INHIBITORY DRUG INTERACTION 4 0.0025
267 EMPYEMA 5 0.0025
268 INFECTED CYST 3 0.0025
269 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 3 0.0025
270 METABOLIC ALKALOSIS 4 0.0025
271 ABDOMINAL ABSCESS 11 0.0025
272 DRUG-INDUCED LIVER INJURY 78 0.0025
273 ENCEPHALITIS VIRAL 3 0.0025
274 ILEUS PARALYTIC 11 0.0025
275 CARDIOVASCULAR INSUFFICIENCY 4 0.0025
276 HYPERTRANSAMINASAEMIA 17 0.0024
277 SEPSIS 270 0.0024
278 ABSCESS 38 0.0024
279 TOOTH DISCOLOURATION 7 0.0024
280 WHITE MATTER LESION 3 0.0024
281 WOUND DEHISCENCE 8 0.0024
282 INTESTINAL ISCHAEMIA 13 0.0024
283 NEUTROPHIL COUNT INCREASED 24 0.0023
284 ACUTE HEPATIC FAILURE 32 0.0023
285 BLOOD AMYLASE INCREASED 4 0.0023
286 THROMBOCYTOPENIA 261 0.0023
287 HYPOALBUMINAEMIA 18 0.0023
288 STAPHYLOCOCCAL INFECTION 76 0.0023
289 ABDOMINAL SEPSIS 2 0.0023
290 BLOOD ALBUMIN DECREASED 18 0.0023
291 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 17 0.0023
292 AZOTAEMIA 9 0.0023
293 HYPERNATRAEMIA 11 0.0022
294 ISCHAEMIC HEPATITIS 3 0.0022
295 HYPERURICAEMIA 9 0.0022
296 PNEUMONIA BACTERIAL 20 0.0022
297 AGRANULOCYTOSIS 40 0.0021
298 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
299 CULTURE URINE POSITIVE 3 0.0021
300 BLOOD UREA ABNORMAL 2 0.0021
301 TRANSPLANT REJECTION 17 0.0021
302 HEPATIC FUNCTION ABNORMAL 77 0.0021
303 DISSEMINATED INTRAVASCULAR COAGULATION 29 0.0021
304 ANTIBIOTIC THERAPY 2 0.0020
305 TOXIC EPIDERMAL NECROLYSIS 31 0.0020
306 HEART VALVE REPLACEMENT 3 0.0020
307 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
308 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 11 0.0020
309 HEPATIC ENZYME ABNORMAL 10 0.0020
310 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
311 NECROTISING FASCIITIS 7 0.0020
312 ORGAN FAILURE 8 0.0020
313 FIBRIN D DIMER INCREASED 7 0.0020
314 HEPATOSPLENOMEGALY 5 0.0019
315 CACHEXIA 10 0.0019
316 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
317 YELLOW SKIN 9 0.0019
318 LUNG OPACITY 5 0.0019
319 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
320 DEVICE RELATED INFECTION 29 0.0019
321 GASTROINTESTINAL TOXICITY 9 0.0019
322 CYTOMEGALOVIRUS INFECTION 31 0.0019
323 MYCOBACTERIUM AVIUM COMPLEX INFECTION 5 0.0019
324 HYPERPHOSPHATAEMIA 4 0.0019
325 OPTIC ATROPHY 3 0.0018
326 DEAFNESS UNILATERAL 10 0.0018
327 DERMATITIS EXFOLIATIVE 9 0.0018
328 EPIGASTRIC DISCOMFORT 7 0.0018
329 GENERALISED OEDEMA 22 0.0018
330 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
331 BONE MARROW FAILURE 36 0.0018
332 GAZE PALSY 3 0.0018
333 ECCHYMOSIS 12 0.0017
334 WOUND COMPLICATION 6 0.0017
335 HERPES VIRUS INFECTION 10 0.0017
336 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
337 ESCHERICHIA SEPSIS 5 0.0017
338 VASCULAR PSEUDOANEURYSM 3 0.0017
339 IMPLANT SITE INFECTION 4 0.0017
340 EXTREMITY NECROSIS 3 0.0017
341 TREATMENT FAILURE 142 0.0017
342 EOSINOPHILIA 30 0.0017
343 ARTHRITIS BACTERIAL 7 0.0017
344 ELECTROCARDIOGRAM QT PROLONGED 61 0.0017
345 HAEMORRHAGIC DIATHESIS 6 0.0017
346 TRANSPLANT DYSFUNCTION 3 0.0017
347 BLOOD CULTURE POSITIVE 5 0.0017
348 LONG QT SYNDROME 4 0.0017
349 KIDNEY TRANSPLANT REJECTION 8 0.0017
350 METABOLIC ENCEPHALOPATHY 5 0.0017
351 ATELECTASIS 16 0.0017
352 ORAL INTAKE REDUCED 4 0.0017
353 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
354 PLATELET COUNT DECREASED 175 0.0016
355 SKIN HYPERPIGMENTATION 14 0.0016
356 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
357 OCULAR ICTERUS 7 0.0016
358 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
359 DEAFNESS 42 0.0016
360 BLOOD BICARBONATE DECREASED 3 0.0016
361 BLOOD BILIRUBIN ABNORMAL 2 0.0016
362 LEUKOCYTOSIS 28 0.0015
363 APNOEA 12 0.0015
364 RESPIRATORY FAILURE 112 0.0015
365 CONCOMITANT DISEASE PROGRESSION 3 0.0015
366 VENOUS THROMBOSIS 6 0.0015
367 OCCULT BLOOD POSITIVE 3 0.0015
368 DRUG LEVEL INCREASED 25 0.0015
369 CARDIAC FAILURE ACUTE 10 0.0015
370 DEVICE RELATED SEPSIS 3 0.0015
371 POTENTIATING DRUG INTERACTION 5 0.0015
372 ANAL ABSCESS 8 0.0015
373 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
374 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 81 0.0015
375 GENERAL PHYSICAL CONDITION ABNORMAL 10 0.0015
376 HYDROCEPHALUS 8 0.0015
377 ABSCESS ORAL 2 0.0015
378 PUSTULAR PSORIASIS 5 0.0015
379 ACUTE RESPIRATORY FAILURE 28 0.0015
380 NEUTROPENIC COLITIS 3 0.0014
381 ASPARTATE AMINOTRANSFERASE INCREASED 77 0.0014
382 STREPTOCOCCAL INFECTION 8 0.0014
383 ENDOTRACHEAL INTUBATION 4 0.0014
384 ENCEPHALOPATHY 35 0.0014
385 BREATH SOUNDS ABNORMAL 7 0.0014
386 ALANINE AMINOTRANSFERASE INCREASED 87 0.0014
387 INTERNATIONAL NORMALISED RATIO INCREASED 40 0.0014
388 ACUTE MYELOID LEUKAEMIA RECURRENT 3 0.0014
389 RASH MACULO-PAPULAR 31 0.0014
390 PNEUMOTHORAX 22 0.0014
391 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0014
392 THROMBOCYTOSIS 5 0.0014
393 BILIARY DILATATION 2 0.0014
394 CLOSTRIDIUM TEST POSITIVE 3 0.0014
395 LUNG INFILTRATION 12 0.0014
396 HYPOPHOSPHATAEMIA 10 0.0014
397 DECUBITUS ULCER 11 0.0013
398 BACTERIAL TEST POSITIVE 3 0.0013
399 LARGE INTESTINAL OBSTRUCTION 3 0.0013
400 LIVER FUNCTION TEST ABNORMAL 39 0.0013
401 MALNUTRITION 15 0.0013
402 JAUNDICE 36 0.0013
403 BRONCHOSPASM 19 0.0013
404 MIXED LIVER INJURY 4 0.0013
405 DISTRIBUTIVE SHOCK 3 0.0013
406 RENAL IMPAIRMENT 111 0.0013
407 RHABDOMYOLYSIS 55 0.0013
408 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
409 GLOMERULAR FILTRATION RATE DECREASED 16 0.0013
410 RENAL FAILURE CHRONIC 10 0.0013
411 HYPOGLYCAEMIA 63 0.0013
412 BRAIN DEATH 4 0.0013
413 C-REACTIVE PROTEIN INCREASED 47 0.0013
414 ELECTROLYTE IMBALANCE 15 0.0013
415 TOXIC SKIN ERUPTION 13 0.0013
416 HYPERKALAEMIA 45 0.0013
417 METABOLIC ACIDOSIS 41 0.0013
418 MYELOSUPPRESSION 46 0.0013
419 PULMONARY MASS 19 0.0013
420 SHOCK 29 0.0013
421 HYPOVOLAEMIC SHOCK 6 0.0013
422 SUBCUTANEOUS ABSCESS 6 0.0013
423 ENTERITIS 8 0.0012
424 ACUTE PULMONARY OEDEMA 7 0.0012
425 LYMPHOCYTE COUNT DECREASED 22 0.0012
426 LYMPHADENITIS 3 0.0012
427 PERONEAL NERVE PALSY 7 0.0012
428 HEPATITIS ACUTE 8 0.0012
429 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
430 TRANSPLANT FAILURE 3 0.0012
431 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
432 PERITONITIS 25 0.0012
433 TACHYARRHYTHMIA 3 0.0012
434 HEPATOCELLULAR INJURY 17 0.0012
435 NEUROTOXICITY 21 0.0012
436 HAEMODIALYSIS 10 0.0012
437 URINARY TRACT INFECTION BACTERIAL 3 0.0012
438 TOXIC ENCEPHALOPATHY 6 0.0012
439 HYPERPYREXIA 5 0.0012
440 BLOOD CREATININE INCREASED 77 0.0012
441 HEPATIC CYST 4 0.0012
442 LACTIC ACIDOSIS 38 0.0012
443 FACIAL PARALYSIS 10 0.0012
444 PURULENT DISCHARGE 5 0.0012
445 ACUTE KIDNEY INJURY 179 0.0012
446 HAEMOLYSIS 9 0.0012
447 REGURGITATION 4 0.0012
448 LEFT VENTRICULAR FAILURE 4 0.0012
449 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
450 TENDERNESS 12 0.0012
451 THROMBOPHLEBITIS 4 0.0011
452 LEUKOPENIA 57 0.0011
453 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
454 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
455 CYTOMEGALOVIRUS VIRAEMIA 5 0.0011
456 TACHYPNOEA 15 0.0011
457 BLOOD PHOSPHORUS INCREASED 3 0.0011
458 CUTANEOUS VASCULITIS 4 0.0011
459 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
460 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
461 HEPATITIS 28 0.0011
462 HYPOTHERMIA 11 0.0011
463 FORCED EXPIRATORY VOLUME DECREASED 3 0.0011
464 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
465 RENAL FAILURE ACUTE 44 0.0010
466 ADENOVIRUS INFECTION 3 0.0010
467 PANCYTOPENIA 57 0.0010
468 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
469 ORGANISING PNEUMONIA 5 0.0010
470 HAEMATOCRIT DECREASED 20 0.0010
471 HYPOMAGNESAEMIA 14 0.0010
472 HAEMOLYTIC ANAEMIA 9 0.0010
473 PROTEIN URINE PRESENT 5 0.0010
474 CIRCULATORY COLLAPSE 17 0.0010
475 OSTEOMYELITIS 18 0.0010
476 SKIN REACTION 14 0.0010
477 CRANIOCEREBRAL INJURY 3 0.0010
478 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
479 STATUS EPILEPTICUS 11 0.0010
480 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
481 RENAL FAILURE 128 0.0010
482 INFUSION SITE EXTRAVASATION 6 0.0010
483 FAILURE TO THRIVE 5 0.0010
484 MOUTH HAEMORRHAGE 7 0.0010
485 BLOOD LACTIC ACID INCREASED 5 0.0009
486 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
487 STEVENS-JOHNSON SYNDROME 21 0.0009
488 BILE DUCT STONE 3 0.0009
489 HEPATIC CYTOLYSIS 12 0.0009
490 GASTROINTESTINAL HAEMORRHAGE 78 0.0009
491 HAEMOPTYSIS 26 0.0009
492 BODY TEMPERATURE INCREASED 19 0.0009
493 GASTROINTESTINAL DISORDER 83 0.0009
494 MYOCLONUS 11 0.0009
495 LYMPHOCYTE COUNT INCREASED 3 0.0009
496 LISTLESS 3 0.0009
497 HEPATIC ENZYME INCREASED 62 0.0009
498 CYSTIC FIBROSIS 5 0.0009
499 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
500 MENTAL STATUS CHANGES 25 0.0009
501 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
502 ILEUS 11 0.0009
503 DRUG INTERACTION 139 0.0009
504 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
505 RESPIRATORY DISTRESS 24 0.0009
506 NEPHROGENIC ANAEMIA 4 0.0009
507 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
508 HYPOKALAEMIA 39 0.0008
509 GANGRENE 5 0.0008
510 WOUND INFECTION 9 0.0008
511 THROMBOTIC MICROANGIOPATHY 8 0.0008
512 NO THERAPEUTIC RESPONSE 10 0.0008
513 RENAL TUBULAR NECROSIS 8 0.0008
514 STAPHYLOCOCCAL SEPSIS 4 0.0008
515 OLIGURIA 5 0.0008
516 HEPATIC STEATOSIS 15 0.0008
517 INTESTINAL PERFORATION 9 0.0008
518 NEUTROPENIA 109 0.0008
519 EPSTEIN-BARR VIRUS INFECTION 5 0.0008
520 DERMATITIS ALLERGIC 10 0.0008
521 OFF LABEL USE 696 0.0008
522 HYPOCALCAEMIA 15 0.0008
523 LIVER FUNCTION TEST INCREASED 17 0.0008
524 BRAIN ABSCESS 2 0.0008
525 TOE AMPUTATION 4 0.0008
526 APPENDICITIS PERFORATED 2 0.0008
527 FEBRILE NEUTROPENIA 52 0.0008
528 HYPOPHAGIA 20 0.0008
529 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 6 0.0008
530 SKIN NECROSIS 4 0.0008
531 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
532 CEREBRAL ATROPHY 3 0.0008
533 MENINGITIS 5 0.0007
534 CANDIDIASIS 3 0.0007
535 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
536 BLOOD SODIUM INCREASED 2 0.0007
537 BRADYPNOEA 2 0.0007
538 CYTOPENIA 9 0.0007
539 DRUG ERUPTION 13 0.0007
540 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
541 DEMYELINATION 3 0.0007
542 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
543 PRODUCT USE IN UNAPPROVED INDICATION 181 0.0007
544 EXTRAVASATION 3 0.0007
545 LEG AMPUTATION 3 0.0007
546 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0007
547 ENCEPHALITIS 5 0.0007
548 PNEUMONIA ASPIRATION 18 0.0007
549 NECROSIS 4 0.0007
550 DRUG INTOLERANCE 69 0.0007
551 CHOLECYSTITIS ACUTE 4 0.0007
552 ABSCESS LIMB 3 0.0007
553 MYDRIASIS 9 0.0007
554 NEUTROPENIC SEPSIS 5 0.0007
555 NEUROLOGICAL SYMPTOM 4 0.0007
556 CYTOKINE RELEASE SYNDROME 14 0.0007
557 UNRESPONSIVE TO STIMULI 18 0.0007
558 CARDIOGENIC SHOCK 10 0.0007
559 MYOPATHY 6 0.0007
560 CARDIAC ARREST 57 0.0007
561 METABOLIC DISORDER 4 0.0007
562 URINE OUTPUT DECREASED 6 0.0007
563 TONGUE DISCOLOURATION 3 0.0007
564 PULMONARY FUNCTION TEST DECREASED 3 0.0007
565 PERIPHERAL SENSORY NEUROPATHY 4 0.0007
566 ENERGY INCREASED 4 0.0007
567 RESPIRATORY RATE INCREASED 6 0.0007
568 CELLULITIS 34 0.0007
569 CONDITION AGGRAVATED 205 0.0007
570 PLEURAL EFFUSION 41 0.0007
571 PETECHIAE 7 0.0007
572 BRAIN HERNIATION 2 0.0007
573 VENTRICULAR TACHYCARDIA 11 0.0007
574 RED BLOOD CELL COUNT DECREASED 19 0.0007
575 TYPE 1 DIABETES MELLITUS 4 0.0007
576 WHITE BLOOD CELL COUNT DECREASED 71 0.0007
577 TINNITUS 30 0.0007
578 DISEASE RECURRENCE 31 0.0007
579 ARTHRITIS INFECTIVE 3 0.0006
580 CHOLANGITIS 4 0.0006
581 HEPATIC ENCEPHALOPATHY 6 0.0006
582 TUBULOINTERSTITIAL NEPHRITIS 12 0.0006
583 RENAL INJURY 19 0.0006
584 ASPIRATION 7 0.0006
585 BLOOD CREATININE DECREASED 2 0.0006
586 COMA 30 0.0006
587 HYPOTENSION 125 0.0006
588 FISTULA 7 0.0006
589 DERMATITIS 13 0.0006
590 SKIN LESION 17 0.0006
591 PANCREATIC DISORDER 3 0.0006
592 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
593 ABDOMINAL TENDERNESS 3 0.0006
594 HYPONATRAEMIA 34 0.0006
595 VOMITING 283 0.0006
596 BK VIRUS INFECTION 2 0.0006
597 DRUG TOLERANCE 3 0.0006
598 COLITIS ISCHAEMIC 4 0.0006
599 BRONCHOPNEUMONIA 2 0.0006
600 ANAEMIA 111 0.0006
601 LUNG INFECTION 9 0.0006
602 DRUG INEFFECTIVE 763 0.0006
603 PROTEINURIA 11 0.0006
604 CARDIO-RESPIRATORY ARREST 24 0.0006
605 IMMUNOSUPPRESSION 5 0.0006
606 RETCHING 12 0.0006
607 NEUROPATHY PERIPHERAL 53 0.0006
608 HAEMOGLOBIN DECREASED 57 0.0006
609 DERMATITIS BULLOUS 4 0.0006
610 OPTIC NEURITIS 5 0.0005
611 INFECTION 79 0.0005
612 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
613 GRAND MAL CONVULSION 5 0.0005
614 HEART RATE ABNORMAL 3 0.0005
615 DIARRHOEA HAEMORRHAGIC 5 0.0005
616 NAUSEA 417 0.0005
617 ACIDOSIS 4 0.0005
618 SINUS BRADYCARDIA 5 0.0005
619 RALES 3 0.0005
620 EJECTION FRACTION DECREASED 8 0.0005
621 ACUTE MYELOID LEUKAEMIA 8 0.0005
622 PULMONARY HAEMORRHAGE 4 0.0005
623 HYPOXIA 18 0.0005
624 FUNGAL INFECTION 17 0.0005
625 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
626 CHOLECYSTITIS 6 0.0005
627 PYREXIA 174 0.0005
628 RESPIRATORY DISORDER 15 0.0005
629 MELAENA 11 0.0005
630 RESPIRATORY TRACT INFECTION 13 0.0005
631 HAEMORRHAGE 52 0.0005
632 ADRENAL INSUFFICIENCY 6 0.0005
633 POLYURIA 4 0.0005
634 SMALL INTESTINAL OBSTRUCTION 6 0.0005
635 PIGMENTATION DISORDER 3 0.0005
636 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
637 EOSINOPHIL COUNT INCREASED 4 0.0005
638 PYELONEPHRITIS 4 0.0005
639 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
640 HERPES SIMPLEX 3 0.0005
641 RASH ERYTHEMATOUS 22 0.0005
642 HYPOGAMMAGLOBULINAEMIA 3 0.0005
643 SKIN MASS 3 0.0004
644 DISEASE PROGRESSION 53 0.0004
645 HAEMARTHROSIS 4 0.0004
646 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
647 SKIN DISCOLOURATION 20 0.0004
648 EXTRASYSTOLES 3 0.0004
649 TACHYCARDIA 38 0.0004
650 MOUTH ULCERATION 9 0.0004
651 OXYGEN SATURATION DECREASED 24 0.0004
652 CHOLELITHIASIS 14 0.0004
653 FLANK PAIN 4 0.0004
654 PAPULE 3 0.0004
655 EPILEPSY 13 0.0004
656 ARTERIOSCLEROSIS 4 0.0004
657 HAEMATOMA 11 0.0004
658 DIALYSIS 6 0.0004
659 SPUTUM DISCOLOURED 4 0.0004
660 HYPERLIPIDAEMIA 5 0.0004
661 ORAL HERPES 8 0.0004
662 PNEUMONIA 132 0.0004
663 CARDIOMEGALY 5 0.0004
664 SECRETION DISCHARGE 5 0.0004
665 IMPAIRED HEALING 13 0.0004
666 TROPONIN INCREASED 3 0.0004
667 AMMONIA INCREASED 2 0.0004
668 BLOOD PRESSURE DECREASED 26 0.0004
669 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
670 VENTRICULAR EXTRASYSTOLES 4 0.0004
671 ABDOMINAL PAIN 89 0.0004
672 HAEMATOCHEZIA 21 0.0004
673 THERAPY NON-RESPONDER 17 0.0004
674 BLOOD DISORDER 3 0.0004
675 ASCITES 11 0.0004
676 PSYCHOTIC DISORDER 11 0.0004
677 HYPOACUSIS 16 0.0004
678 DECREASED APPETITE 86 0.0004
679 BLOOD POTASSIUM INCREASED 6 0.0004
680 COLITIS 14 0.0004
681 CHRONIC KIDNEY DISEASE 28 0.0004
682 CEREBRAL INFARCTION 9 0.0004
683 NEUTROPHIL COUNT DECREASED 15 0.0004
684 PALLOR 10 0.0004
685 CONVULSION 21 0.0004
686 HICCUPS 3 0.0004
687 POST PROCEDURAL COMPLICATION 7 0.0004
688 SEROTONIN SYNDROME 7 0.0004
689 VENTRICULAR FIBRILLATION 4 0.0004
690 ANGIOPATHY 2 0.0004
691 HAEMATEMESIS 9 0.0004
692 NERVOUS SYSTEM DISORDER 11 0.0004
693 SINUS TACHYCARDIA 5 0.0004
694 MYOCARDIAL ISCHAEMIA 4 0.0004
695 OEDEMA 19 0.0003
696 ANAPHYLACTIC SHOCK 9 0.0003
697 MYOCARDITIS 4 0.0003
698 EYELID OEDEMA 4 0.0003
699 GASTROENTERITIS 5 0.0003
700 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
701 TUMOUR LYSIS SYNDROME 3 0.0003
702 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
703 ATAXIA 4 0.0003
704 CARDIOTOXICITY 3 0.0003
705 CARDIAC FAILURE CONGESTIVE 27 0.0003
706 LIP SWELLING 11 0.0003
707 DIARRHOEA 213 0.0003
708 END STAGE RENAL DISEASE 6 0.0003
709 ATRIAL FIBRILLATION 32 0.0003
710 UROSEPSIS 3 0.0003
711 CARDIAC FAILURE 26 0.0003
712 HAEMATOTOXICITY 3 0.0003
713 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
714 HYPERCHOLESTEROLAEMIA 3 0.0003
715 RASH GENERALISED 8 0.0003
716 VITAMIN D DEFICIENCY 3 0.0003
717 HEPATOMEGALY 3 0.0003
718 VITREOUS FLOATERS 3 0.0003
719 THERAPY CHANGE 3 0.0003
720 BODY TEMPERATURE DECREASED 3 0.0003
721 ORAL CANDIDIASIS 4 0.0003
722 PRODUCT USE ISSUE 57 0.0003
723 TOXICITY TO VARIOUS AGENTS 51 0.0003
724 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
725 BRADYCARDIA 16 0.0003
726 DEATH 258 0.0003
727 BREAST MASS 2 0.0003
728 EMPHYSEMA 3 0.0003
729 PERITONITIS BACTERIAL 3 0.0003
730 ABDOMINAL DISTENSION 31 0.0003
731 FACE OEDEMA 5 0.0003
732 LETHARGY 17 0.0003
733 DRUG LEVEL DECREASED 3 0.0003
734 PNEUMONITIS 8 0.0003
735 DRUG TOXICITY 4 0.0003
736 IMPAIRED GASTRIC EMPTYING 4 0.0003
737 LIVER DISORDER 13 0.0003
738 PERIPHERAL COLDNESS 4 0.0003
739 PULMONARY OEDEMA 13 0.0003
740 RESPIRATORY ARREST 8 0.0003
741 CHILLS 33 0.0003
742 BREAST PAIN 3 0.0003
743 OEDEMA PERIPHERAL 34 0.0003
744 DEEP VEIN THROMBOSIS 18 0.0003
745 FAECES DISCOLOURED 6 0.0003
746 PRODUCT PRESCRIBING ISSUE 6 0.0003
747 HYPERGLYCAEMIA 10 0.0003
748 PULMONARY EMBOLISM 26 0.0003
749 PRODUCTIVE COUGH 13 0.0003
750 BLINDNESS TRANSIENT 2 0.0003
751 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
752 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
753 CARDIOMYOPATHY 4 0.0003
754 HAEMORRHAGE INTRACRANIAL 4 0.0003
755 SKIN INFECTION 3 0.0003
756 MUCOSAL INFLAMMATION 7 0.0003
757 MITRAL VALVE INCOMPETENCE 3 0.0003
758 APHASIA 8 0.0003
759 DEHYDRATION 35 0.0003
760 FREQUENT BOWEL MOVEMENTS 7 0.0003
761 WEIGHT DECREASED 72 0.0003
762 RASH MACULAR 9 0.0003
763 BLOOD CHOLESTEROL INCREASED 12 0.0003
764 THERAPY PARTIAL RESPONDER 4 0.0003
765 PROCEDURAL PAIN 7 0.0003
766 MUSCLE RIGIDITY 3 0.0003
767 FULL BLOOD COUNT DECREASED 5 0.0002
768 DYSURIA 9 0.0002
769 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
770 INFUSION RELATED REACTION 16 0.0002
771 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
772 PERICARDITIS 4 0.0002
773 CARDIOVASCULAR DISORDER 6 0.0002
774 THROMBOSIS 19 0.0002
775 HEMIPARESIS 4 0.0002
776 CONFUSIONAL STATE 38 0.0002
777 SCAR 4 0.0002
778 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
779 DELIRIUM 8 0.0002
780 MENTAL DISORDER 10 0.0002
781 PULMONARY CONGESTION 3 0.0002
782 ADVERSE REACTION 3 0.0002
783 CHROMATURIA 5 0.0002
784 RASH 95 0.0002
785 ABNORMAL DREAMS 6 0.0002
786 PERICARDIAL EFFUSION 5 0.0002
787 ERYTHEMA 44 0.0002
788 BLOOD TEST ABNORMAL 3 0.0002
789 INFLAMMATION 11 0.0002
790 HEPATIC CIRRHOSIS 4 0.0002
791 BLOOD SODIUM DECREASED 4 0.0002
792 ARRHYTHMIA 10 0.0002
793 URINARY TRACT INFECTION 36 0.0002
794 DYSPHAGIA 20 0.0002
795 PARALYSIS 3 0.0002
796 SUBDURAL HAEMATOMA 3 0.0002
797 INTERSTITIAL LUNG DISEASE 10 0.0002
798 FLUID OVERLOAD 3 0.0002
799 NEURALGIA 5 0.0002
800 HAEMATURIA 7 0.0002
801 LUNG DISORDER 10 0.0002
802 ACUTE MYOCARDIAL INFARCTION 6 0.0002
803 BLOOD PRESSURE ABNORMAL 4 0.0002
804 HEART RATE DECREASED 7 0.0002
805 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
806 CORONARY ARTERY DISEASE 6 0.0002
807 ECONOMIC PROBLEM 3 0.0002
808 OSTEOPENIA 3 0.0002
809 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
810 NEPHROLITHIASIS 9 0.0002
811 CEREBRAL HAEMORRHAGE 7 0.0002
812 CHEST DISCOMFORT 20 0.0002
813 PHARYNGEAL OEDEMA 3 0.0002
814 LYMPHOMA 3 0.0002
815 SKIN ULCER 5 0.0002
816 SWOLLEN TONGUE 6 0.0002
817 SEIZURE 22 0.0002
818 ULCER 3 0.0002
819 OBESITY 3 0.0002
820 ABDOMINAL DISCOMFORT 31 0.0002
821 HYPERSENSITIVITY 34 0.0002
822 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
823 WOUND 5 0.0002
824 BLOOD CALCIUM DECREASED 2 0.0002
825 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
826 MUSCLE TWITCHING 4 0.0002
827 HALLUCINATION 13 0.0002
828 ORTHOSTATIC HYPOTENSION 3 0.0002
829 ABDOMINAL PAIN UPPER 35 0.0002
830 BLOOD POTASSIUM DECREASED 5 0.0002
831 HYPERTENSION 35 0.0002
832 PRESYNCOPE 4 0.0002
833 VERTIGO 10 0.0002
834 PALPITATIONS 19 0.0002
835 HEART RATE INCREASED 16 0.0002
836 DYSPNOEA 91 0.0002
837 BLISTER 9 0.0002
838 DYSPNOEA EXERTIONAL 6 0.0002
839 BRAIN OEDEMA 2 0.0002
840 HEAD INJURY 5 0.0002
841 MUSCULOSKELETAL DISORDER 3 0.0002
842 URTICARIA 26 0.0002
843 ANOREXIA 2 0.0002
844 EAR PAIN 3 0.0002
845 BLOOD GLUCOSE INCREASED 29 0.0002
846 HAEMORRHOIDS 3 0.0002
847 KIDNEY INFECTION 3 0.0002
848 ANHEDONIA 4 0.0002
849 RENAL DISORDER 7 0.0002
850 DYSGEUSIA 11 0.0001
851 FEEDING DISORDER 3 0.0001
852 RIB FRACTURE 3 0.0001
853 DIABETES MELLITUS 11 0.0001
854 PULMONARY HYPERTENSION 3 0.0001
855 APHONIA 2 0.0001
856 COUGH 40 0.0001
857 BLINDNESS UNILATERAL 2 0.0001
858 LYMPHADENOPATHY 5 0.0001
859 BALANCE DISORDER 12 0.0001
860 PRURITUS 53 0.0001
861 DYSPHONIA 8 0.0001
862 AGITATION 10 0.0001
863 ASTHENIA 51 0.0001
864 LABORATORY TEST ABNORMAL 4 0.0001
865 CHEST PAIN 25 0.0001
866 RASH PAPULAR 3 0.0001
867 MALAISE 57 0.0001
868 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
869 INJURY 9 0.0001
870 ANAPHYLACTIC REACTION 7 0.0001
871 BLOOD GLUCOSE DECREASED 6 0.0001
872 MOVEMENT DISORDER 4 0.0001
873 HYPERHIDROSIS 16 0.0001
874 SOMNOLENCE 25 0.0001
875 NIGHT SWEATS 4 0.0001
876 LOCALISED INFECTION 3 0.0001
877 DYSKINESIA 5 0.0001
878 SWELLING FACE 8 0.0001
879 DYSPEPSIA 12 0.0001
880 EYE DISORDER 4 0.0001
881 BRONCHITIS 9 0.0001
882 EXTRAPYRAMIDAL DISORDER 3 0.0001
883 OVERDOSE 26 0.0001
884 VISUAL ACUITY REDUCED 4 0.0001
885 EPISTAXIS 9 0.0001
886 SYNCOPE 12 0.0001
887 SKIN DISORDER 4 0.0001
888 SWELLING 11 0.0001
889 NEOPLASM PROGRESSION 4 0.0001
890 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
891 SEDATION 3 0.0001
892 MUSCULAR WEAKNESS 13 0.0001
893 BACK PAIN 26 0.0001
894 GASTROOESOPHAGEAL REFLUX DISEASE 9 0.0001
895 FATIGUE 87 0.0001
896 FEAR 3 0.0001
897 RASH PRURITIC 6 0.0001
898 LIMB INJURY 3 0.0001
899 BONE DISORDER 2 0.0001
900 LOSS OF CONSCIOUSNESS 14 0.0001
901 ARTHROPATHY 6 0.0001
902 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
903 SINUSITIS 11 0.0001
904 SKIN EXFOLIATION 9 0.0001
905 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
906 DYSSTASIA 3 0.0001
907 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
908 WHEEZING 6 0.0001
909 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
910 DISORIENTATION 4 0.0001
911 CONSTIPATION 22 0.0001
912 DISCOMFORT 6 0.0001
913 FLUID RETENTION 5 0.0001
914 ADVERSE EVENT 9 0.0001
915 OSTEOPOROSIS 4 0.0001
916 ILLNESS 10 0.0001
917 CARDIAC DISORDER 9 0.0001
918 MUSCULOSKELETAL PAIN 5 0.0001
919 TREATMENT NONCOMPLIANCE 5 0.0001
920 TREMOR 15 0.0001
921 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
922 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
923 FLUSHING 9 0.0001
924 HERPES ZOSTER 5 0.0001
925 BURNING SENSATION 6 0.0001
926 COVID-19 15 0.0001
927 RESTLESSNESS 3 0.0001
928 ABASIA 2 0.0001
929 AGEUSIA 2 0.0001
930 INTESTINAL OBSTRUCTION 3 0.0001
931 UNEVALUABLE EVENT 6 0.0001
932 ABDOMINAL PAIN LOWER 2 0.0001
933 INSOMNIA 21 0.0001
934 DIZZINESS 39 0.0001
935 THERAPY CESSATION 4 0.0001
936 ECZEMA 4 0.0001
937 WEIGHT INCREASED 17 0.0001
938 DEPRESSED MOOD 4 0.0001
939 MEDICATION ERROR 4 0.0001
940 BLOOD PRESSURE INCREASED 11 0.0001
941 ROAD TRAFFIC ACCIDENT 3 0.0001
942 NECK PAIN 4 0.0001
943 OSTEOARTHRITIS 3 0.0001
944 THERAPY INTERRUPTED 5 0.0001
945 ANGINA PECTORIS 2 0.0001
946 DEVICE DISLOCATION 3 0.0001
947 MYOCARDIAL INFARCTION 12 0.0001
948 GAIT DISTURBANCE 13 0.0001
949 ANGIOEDEMA 3 0.0001
950 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
951 ADVERSE DRUG REACTION 6 0.0001
952 ANXIETY 19 0.0001
953 ILL-DEFINED DISORDER 4 0.0001
954 OROPHARYNGEAL PAIN 6 0.0001
955 EXPOSURE DURING PREGNANCY 4 0.0001
956 CONTUSION 6 0.0001
957 DEPRESSION 14 0.0001
958 VISION BLURRED 8 0.0001
959 PAIN IN EXTREMITY 17 0.0001
960 PARAESTHESIA 9 0.0001
961 FALL 19 0.0001
962 ARTHRALGIA 23 0.0001
963 HYPOAESTHESIA 8 0.0001
964 MYALGIA 9 0.0001
965 CATARACT 3 0.0001
966 DRY MOUTH 4 0.0000
967 BLINDNESS 2 0.0000
968 CEREBROVASCULAR ACCIDENT 8 0.0000
969 HEADACHE 28 0.0000
970 PRODUCT QUALITY ISSUE 6 0.0000
971 NO ADVERSE EVENT 8 0.0000
972 SUICIDAL IDEATION 4 0.0000
973 JOINT SWELLING 5 0.0000
974 ACNE 3 0.0000
975 HOSPITALISATION 6 0.0000
976 PERIPHERAL SWELLING 6 0.0000
977 ARTHRITIS 3 0.0000
978 DRY SKIN 5 0.0000
979 PAIN 21 0.0000
980 PRODUCT DOSE OMISSION ISSUE 9 0.0000
981 ALOPECIA 6 0.0000
982 FEELING ABNORMAL 7 0.0000
983 MUSCLE SPASMS 5 0.0000
984 INFLUENZA 3 0.0000
985 INCORRECT DOSE ADMINISTERED 6 0.0000
986 EMOTIONAL DISTRESS 3 0.0000
987 DRUG DEPENDENCE 3 0.0000
988 ASTHMA 2 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000